Caption People sit around a table for a group discussion Understanding symptoms early after Parkinson’s diagnosis Date 19 July 2022 An important research partnership involving Parkinson’s UK, pharmaceutical company UCB and the Parkinson’s Foundation has published their first results in a study designed alongside people living with Parkinson’s.
Progress towards Apple Watch based tracking of symptoms Date 17 June 2022 An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson’s.
Save Parkinson’s clinical research. Take part today Date 8 June 2022 We’re calling on the Parkinson’s community to take part in 5 important clinical studies that are currently at risk of closure.
Caption Drug discovery research NRG Therapeutics awarded £2.68m to develop treatments that could slow Parkinson's Date 30 May 2022 Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Researchers find brain scans linked to the severity of Parkinson’s symptoms Date 19 May 2022 Research led by Cambridge University and part funded by Parkinson’s UK shows that a form of brain scan could help identify those at risk of specific Parkinson’s symptoms.
Clinical trial of world’s smallest deep brain stimulation device hits headlines Date 27 April 2022 A trial of a new miniaturised deep brain stimulation (DBS) device, being carried out at Southmead Hospital in Bristol, aims to make improvements to existing surgery.
Progress made in partnership between pharma and people with Parkinson's Date 27 April 2022 A pioneering partnership between global biopharmaceutical company UCB, Parkinson’s UK and the Parkinson's Foundation in the US is laying the foundations for people with Parkinson's to feed into the drug development pipeline.
New smartwatch has potential to enhance personalised Parkinson’s care Date 19 April 2022 As a new clinical trial begins, we explore the potential and next steps for a Parkinson’s watch that monitors symptoms.
Caption Husband and wife look out the window Pioneering clinical trial opens new sites Date 6 April 2022 The TOP HAT clinical trial for visual hallucinations in Parkinson's and Lewy body dementia has recently opened 4 new trial sites.
Investigating an app to improve non-motor symptom management Date 21 March 2022 An app for people with Parkinson’s to remotely monitor and manage their non-motor symptoms is now entering the testing phase.
